Aprea Therapeutics, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 2.71%170.480.7%$1278.24m
PFEPfizer Inc. 0.07%37.310.9%$1194.50m
LLYEli Lilly & Co. 0.31%213.001.1%$1020.03m
ABBVAbbVie, Inc. -1.53%108.811.9%$749.27m
AZNAstraZeneca Plc 0.80%54.441.2%$709.95m
MRKMerck & Co., Inc. -1.06%80.290.7%$700.46m
BMYBristol-Myers Squibb Co. -0.60%64.441.0%$698.52m
ARCTArcturus Therapeutics Holdings, Inc. -6.41%64.990.0%$222.82m
VTRSViatris, Inc. -0.81%17.090.0%$196.54m
RPRXRoyalty Pharma Plc 2.56%52.820.2%$185.48m
NVSNovartis AG -2.60%95.910.2%$184.97m
GSKGlaxoSmithKline Plc 0.82%39.240.2%$163.38m
GRTSGritstone Oncology, Inc. -13.83%20.560.0%$162.66m
SNYSanofi -0.97%49.150.2%$137.60m
TAKTakeda Pharmaceutical Co., Ltd. -0.98%18.190.0%$80.46m

Company Profile

Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA.